Bicocca Open Archive

Logo unimib boa
QUARTI TREVANO, FOSCA ANNA LUISA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 15.888
AS - Asia 11.455
EU - Europa 7.197
SA - Sud America 1.704
AF - Africa 289
OC - Oceania 22
Continente sconosciuto - Info sul continente non disponibili 11
Totale 36.566
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 15.537
SG - Singapore 3.853
CN - Cina 2.344
VN - Vietnam 2.156
HK - Hong Kong 1.473
RU - Federazione Russa 1.335
BR - Brasile 1.294
DE - Germania 1.164
IT - Italia 1.114
SE - Svezia 952
IE - Irlanda 675
UA - Ucraina 464
GB - Regno Unito 390
FR - Francia 333
IN - India 329
KR - Corea 242
CA - Canada 212
FI - Finlandia 202
BD - Bangladesh 162
AR - Argentina 148
IQ - Iraq 135
AT - Austria 134
ID - Indonesia 126
TR - Turchia 107
ZA - Sudafrica 97
MX - Messico 80
PK - Pakistan 80
JP - Giappone 75
NL - Olanda 69
ES - Italia 66
PL - Polonia 65
SA - Arabia Saudita 64
PH - Filippine 60
CO - Colombia 57
EC - Ecuador 56
VE - Venezuela 56
DK - Danimarca 43
UZ - Uzbekistan 43
KE - Kenya 32
EG - Egitto 27
MY - Malesia 26
BE - Belgio 25
CZ - Repubblica Ceca 25
TN - Tunisia 25
MA - Marocco 24
PY - Paraguay 24
CL - Cile 23
ET - Etiopia 23
AU - Australia 22
JO - Giordania 20
LT - Lituania 20
AE - Emirati Arabi Uniti 16
NP - Nepal 16
PE - Perù 16
DZ - Algeria 15
AL - Albania 13
AZ - Azerbaigian 13
BO - Bolivia 13
RO - Romania 13
UY - Uruguay 13
IR - Iran 12
CH - Svizzera 11
EE - Estonia 11
JM - Giamaica 11
LB - Libano 11
BG - Bulgaria 10
BY - Bielorussia 10
KZ - Kazakistan 10
TW - Taiwan 10
HN - Honduras 9
HU - Ungheria 9
LK - Sri Lanka 9
MK - Macedonia 9
PS - Palestinian Territory 8
PT - Portogallo 8
CI - Costa d'Avorio 7
CR - Costa Rica 7
DO - Repubblica Dominicana 7
IL - Israele 7
PA - Panama 7
SN - Senegal 7
GE - Georgia 6
NG - Nigeria 6
OM - Oman 6
XK - ???statistics.table.value.countryCode.XK??? 6
BA - Bosnia-Erzegovina 5
BH - Bahrain 5
KG - Kirghizistan 5
RS - Serbia 5
TH - Thailandia 5
EU - Europa 4
MU - Mauritius 4
NI - Nicaragua 4
SY - Repubblica araba siriana 4
TT - Trinidad e Tobago 4
AM - Armenia 3
AO - Angola 3
GR - Grecia 3
HR - Croazia 3
KH - Cambogia 3
Totale 36.510
Salva come PNG Salva come JPEG
Città #
Singapore 2.227
Ann Arbor 2.182
Ashburn 1.540
Hong Kong 1.447
San Jose 1.066
Fairfield 986
Woodbridge 936
Houston 711
Frankfurt am Main 706
Ho Chi Minh City 650
Dublin 637
Chandler 572
Hanoi 516
Wilmington 515
Dallas 512
Jacksonville 470
Hefei 467
New York 367
Seattle 367
Beijing 355
Dearborn 318
Milan 317
Chicago 314
Cambridge 307
Santa Clara 284
Los Angeles 269
Princeton 246
Seoul 232
The Dalles 216
Lauterbourg 156
Moscow 150
Shanghai 124
Lawrence 121
Altamura 120
São Paulo 115
Nanjing 114
Vienna 110
Da Nang 96
Buffalo 95
Munich 89
Orem 81
Helsinki 77
Haiphong 75
Lachine 73
Jakarta 71
San Diego 68
Guangzhou 66
Council Bluffs 59
Boardman 58
Baghdad 55
Chennai 53
London 53
Lissone 50
Rio de Janeiro 49
Tokyo 49
Rome 47
Warsaw 47
Dong Ket 44
Toronto 44
Andover 42
Nuremberg 42
Hangzhou 41
Quận Bình Thạnh 40
Denver 38
Nanchang 38
Tashkent 38
Atlanta 37
Johannesburg 37
Changsha 36
Turku 36
Ha Long 35
Tianjin 35
Brooklyn 33
Salt Lake City 32
Can Tho 31
Düsseldorf 31
Hebei 31
Hải Dương 31
Dhaka 30
Montreal 28
Zhengzhou 28
Mumbai 27
Ninh Bình 27
Vũng Tàu 27
Biên Hòa 26
Fremont 25
Thái Nguyên 25
Belo Horizonte 24
Falls Church 24
Jiaxing 24
Kent 24
Phoenix 24
San Francisco 24
Brasília 23
Lahore 23
Brussels 22
Jinan 22
Monza 22
Nairobi 22
New Delhi 22
Totale 23.368
Salva come PNG Salva come JPEG
Nome #
Understanding Factors Associated With Psychomotor Subtypes of Delirium in Older Inpatients With Dementia 462
Baroreceptors as a target of device-based neuromodulation in heart failure: Long-term outcomes 453
Contrasting effects of carotid baroreceptor stimulation on regional sympathetic drive in chronic human heart failure 440
Heart rate as a sympathetic marker during acute adrenergic challenge 421
Sympathetic Overactivation in the Resistant Hypertensive Phenotype: A Meta-Analysis of Published Studies 410
Reliability of heart rate as neuroadrenergic marker in the metabolic syndrome. 335
Left ventricular hypertrophy increases cardiovascular risk independently of in-office and out-of-office blood pressure values 321
Sympathetic Neural Overdrive in the Obese and Overweight State: Meta-Analysis of Published Studies 321
Sympathetic and baroreflex alterations in congestive heart failure with preserved, midrange and reduced ejection fraction. 311
Long-term risk of diabetes, hypertension and left ventricular hypertrophy associated with the metabolic syndrome in a general population 308
Habitual coffee consumption and risk of cardiovascular and all-cause mortality in the PAMELA hypertensive population 292
Neurogenic abnormalities in masked hypertension 288
Metabolic syndrome in the Pressioni Arteriose Monitorate E Loro Associazioni (PAMELA) study: daily life blood pressure, cardiac damage, and prognosis 287
Prevalence of cardiovascular risk factors in an unselected Italian population. Results of the CardioLab Project 2004-2008 282
Neuroadrenergic and reflex abnormalities in patients with metabolic syndrome 278
Sympathetic nerve traffic and baroreflex function in optimal, normal, and high-normal blood pressure states 277
Sympathetic and baroreflex abnormalities in the uncomplicated prediabetic state 271
Sympathetic overdrive in the metabolic syndrome: meta-analysis of published studies 270
Efficacy and tolerability profile of nebivolol vs atenolol in mild-to-moderate essential hypertension: Results of a double-blind randomized multicentre trial 268
Iron Overload Increases Sympathetic Nervous Activity: Study in Hemochromatosis Patients at Diagnosis and Iron Depletion 267
Excessive sympathetic activation in heart failure with obesity and metabolic syndrome: Characteristics and mechanisms 266
Impact of different definitions of the metabolic syndrome on the prevalence of organ damage, cardiometabolic risk and cardiovascular events 265
Endocan, a novel marker of endothelial dysfunction in patients with essential hypertension: comparative effects of amlodipine and valsartan 265
Effect of central and peripheral body fat distribution on sympathetic and baroreflex function in obese normotensives 263
Angiotensin-sympathetic system interactions in cardiovascular and metabolic disease 262
Threshold and Target for Blood Pressure Lowering in the Elderly 260
DIFFERING EFFECTS OF RENAL DENERVATION ON BLOOD PRESSURE AND SYMPATHETIC NERVE TRAFFIC: A SYSTEMATIC REVIEW AND META-ANALYSIS 259
Sustained sympathoinhibitory effects of cardiac resynchronization therapy in severe heart failure 259
Heart Rate, Sympathetic Cardiovascular Influences, and The Metabolic Syndrome 259
Structural and functional alterations of subcutaneous small resistance arteries in severe human obesity 259
Increased long-term risk of new-onset diabetes mellitus in white-coat and masked hypertension 258
Multiple sampling improves norepinephrine reproducibility in essential hypertension: a comparison with the microneurographic technique 257
Relationships between diuretic-related hyperuricemia and cardiovascular events: data from the URic acid Right for heArt Health study 252
Renal Denervation in End-Stage Renal Disease: Current Evidence and Perspectives 249
Effects of long-term lercanidipine or hydrochlorothiazide administration on hypertension-related vascular structural changes 249
Long-term prognostic value of blood pressure variability in the general population: results of the Pressioni Arteriose Monitorate e Loro Associazioni Study 249
Neuroadrenergic activation in obstructive sleep apnoea syndrome: A new selectedmeta-analysis - revisited 249
Serum uric acid and fatal myocardial infarction: detection of prognostic cut-off values: The URRAH (Uric Acid Right for Heart Health) study 247
Iron overload exerts sympathoexcitatory effects in men with essential hypertension: microneurogtaphic evidence 245
Multicenter Randomized Double-Blind Comparison of Nebivolol plus HCTZ and Irbesartan plus HCTZ in the Treatment of Isolated Systolic Hypertension in Elderly Patients: Results of the NEHIS Study 244
Short- and long-term neuroadrenergic effects of moderate dietary sodium restriction in essential hypertension 240
Diurnal blood pressure variation and sympathetic activity 239
Multicentre randomised, double blind, evaluation of nebivolol plus HCTZ and irbesartan plus HCTZ in the treatment of systolic hypertension in the elderly: the NEHIS Study 239
Effects of hypertension and obesity on the sympathetic activation of heart failure patients 237
Long-term chronic baroreflex activation: persistent efficacy in patients with heart failure and reduced ejection fraction 236
Sympathetic and baroreflex cardiovascular control in hypertension-related left ventricular dysfunction 235
SYMPATHETIC OVERDRIVE IN THE RESISTANT HYPERTENSIVE PHENOTYPE 234
Behaviour of regional sympathetic nerve traffic in obstructive sleep apnea syndrome 232
Hypertension, antihypertensive treatment and stroke prevention 229
Cardiovascular risk and adrenergic overdrive in the metabolic syndrome 229
Should white-coat hypertension in diabetes be treated? Pro 229
Total cardiovascular risk, blood pressure variability and adrenergic overdrive in hypertension: evidence, mechanisms and clinical implications 229
Response to possible difference in the sympathetic activation on extreme dippers with or without exaggerated morining surge 228
Adrenergic and metabolic effects of bariatric surgey in obese subjects: a longitudinal study 228
Effects of acute carotid baroreceptor stimulation on sympathetic nerve traffic in resistant and uncontrolled hypertension: a systematic review and meta-analysis 227
Sympathetic neural abnormalities in type 1 and type 2 diabetes: a systematic review and meta-analysis 227
Sympathetic Nerve Traffic and Arterial Baroreflex Function in Apparent Drug-Resistant Hypertension 226
Incident Left Ventricular Hypertrophy in Masked Hypertension 224
Triglyceride-glucose Index and Mortality in a Large Regional-based Italian Database (Urrah Project) 222
The PAMELA (Pressioni Arteriose Monitorate E Loro Associazioni) study: Main features and results 221
Follow-up of Antihypertensive Therapy Improves Blood Pressure Control: Results of HYT (HYperTension survey) Follow-up 221
Autonomic Cardiovascular Alterations in Chronic Kidney Disease: Effects of Dialysis, Kidney Transplantation, and Renal Denervation 220
Long-term risk of sustained hypertension in white-coat or masked hypertension 212
Early sympathetic activation in the initial clinical stages of chronic renal failure 212
Primary and secondary prevention of stroke by antihypertensive treatment in clinical trials 212
Baroreflex function in hypertension: consequences for antihypertensive therapy 212
Cardioprotective effects of telmisartan in uncomplicated and complicated hypertension 211
Early sympathetic activation in mild renal failure 210
Blood pressure lowering effects of Rimonabant in obesità-related hypertension 209
4C.07:Relationships between cognitive dysfunction, clinic and ambulatory blood pressure and blood pressure variability: results from the PAMELA Study 209
HYT-Hypertension in Turkey: A Cross-Sectional Survey on Blood Pressure Control with Calcium Channel Blockers Alone or Combined with Other Antihypertensive Drugs 206
Association Between Arterial Stiffness, High Blood Pressure, and Hypertensive Phenotypes: Insights from the PAMELA Study 204
The "J curve" problem revisited: old and new findings 204
New onset left atrial dilatation in the general population: A quarter-century follow-up 203
Long-term increase in serum uric acid and its predictors over a 25 year follow-up: Results of the PAMELA study 203
Adrenergic, metabolic, and reflex abnormalities in reverse and extreme dipper hypertensives 203
FAILURE OF ANTIHYPERTENSIVE TREATMENT TO RESTORE NORMAL SYMPATHETIC ACTIVITY 202
Sympathetic neural overdrive in congestive heart failure and its correlates: systematic reviews and meta-analysis 202
Pheochromocytoma as a Clinical Model of Peripheral Sympathetic Overdrive: Old and New Findings 202
Obstructive sleep apnea-dependent and -independent adrenergic activation in obesity 201
Left ventricular mass reduction and hypertrophy regression following renal artery revascularization: a meta-analysis 200
Sympathetic activation in congestive heart failure: an updated overview 199
Association between ADRA1A gene and the metabolic syndrome: Candidate genes and functional counterpart in the PAMELA population 198
Failure of Antihypertensive Treatment to Restore Normal Sympathetic Activity 197
Reinforcement of the adrenergic overdrive in the metabolic syndrome complicated by obstructive sleep apnea 197
Hyperuricemia and Risk of Cardiovascular Outcomes: The Experience of the URRAH (Uric Acid Right for Heart Health) Project 197
Clinical correlates and subclinical cardiac organ damage in different extreme dipping patterns 196
Blood pressure control in resistant hypertension: new therapeutic options 195
Sympathetic activation in congestive heart failure: Evidence, consequences and therapeutic implications 194
Left ventricular hypertrophy in isolated and dual masked hypertension 191
The 'neuroadrenergic hypothesis' in hypertension: current evidence 190
Salt intake and sympathetic activity - Response 189
Response to sympathetic activity, heart failure, obesity, and metabolic syndrome: Is there any role for obstructive sleep apnea? 187
Essential hypertension and the sympathetic nervous system 187
Blood pressure control and therapeutic modulation of the adrenergic overdrive 187
Comparative effects of candesartan and hydrochlorothiazide on blood pressure, insulin sensitivity, and sympathetic drive in obese hypertensive individuals: Results of the CROSS study 187
Habitual coffee consumption and office, home, and ambulatory blood pressure: results of a 10-year prospective study 184
Habitual Regular Coffee Consumption And Arterial Stiffness -Data From The 3rd Pamela Survey 184
Cardio-Ankle Vascular Index As A Marker Of Left Ventricular Hypertrophy In Treated Hypertensives: Findings From The Pamela Study 183
Antihypertensive treatment and stroke prevention: From recent meta-analyses to the PRoFESS trial 182
Totale 24.271
Salva come PNG Salva come JPEG
Categoria #
all - tutte 122.823
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 122.823
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021388 0 0 0 0 0 0 0 0 0 0 140 248
2021/20222.063 165 171 263 201 177 162 110 83 110 128 195 298
2022/20232.814 320 813 274 271 165 453 48 157 159 20 89 45
2023/20242.231 56 56 112 120 298 501 387 74 252 67 51 257
2024/20256.380 321 721 250 268 518 185 299 278 607 979 723 1.231
2025/202614.944 2.287 1.440 1.433 1.748 1.576 825 2.174 752 1.243 1.461 5 0
Totale 37.216